BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16966330)

  • 1. Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF.
    Lamalice L; Houle F; Huot J
    J Biol Chem; 2006 Nov; 281(45):34009-20. PubMed ID: 16966330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetic Control for Investigating Subcellular Localization of Fyn Kinase Activity in Single Live Cells.
    Huang Z; Ouyang M; Lu S; Wang Y; Peng Q
    J Mol Biol; 2020 Mar; 432(7):1901-1909. PubMed ID: 32198118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer.
    Zhu X; Zhou W
    Front Endocrinol (Lausanne); 2015; 6():159. PubMed ID: 26500608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
    Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L
    J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies.
    Shibuya M
    Genes Cancer; 2011 Dec; 2(12):1097-105. PubMed ID: 22866201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.
    Shalaby F; Rossant J; Yamaguchi TP; Gertsenstein M; Wu XF; Breitman ML; Schuh AC
    Nature; 1995 Jul; 376(6535):62-6. PubMed ID: 7596435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer Action of Silver Nanoparticles in SKBR3 Breast Cancer Cells through Promotion of Oxidative Stress and Apoptosis.
    Vahabirad M; Daei S; Abbasalipourkabir R; Ziamajidi N
    Biomed Res Int; 2024; 2024():7145339. PubMed ID: 38410788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acrizanib as a Novel Therapeutic Agent for Fundus Neovascularization via Inhibitory Phosphorylation of VEGFR2.
    Tang X; Cui K; Wu P; Hu A; Fan M; Lu X; Yang F; Lin J; Yu S; Xu Y; Liang X
    Transl Vis Sci Technol; 2024 Jan; 13(1):1. PubMed ID: 38165719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of ARID1A-interacting proteins in renal tubular cells and their molecular regulation of angiogenesis.
    Yoodee S; Peerapen P; Plumworasawat S; Malaitad T; Thongboonkerd V
    J Transl Med; 2023 Nov; 21(1):862. PubMed ID: 38017409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FYN: emerging biological roles and potential therapeutic targets in cancer.
    Peng S; Fu Y
    J Transl Med; 2023 Feb; 21(1):84. PubMed ID: 36740671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes derived from dental pulp stem cells accelerate cutaneous wound healing by enhancing angiogenesis via the Cdc42/p38 MAPK pathway.
    Zhou Z; Zheng J; Lin D; Xu R; Chen Y; Hu X
    Int J Mol Med; 2022 Dec; 50(6):. PubMed ID: 36321793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-(2-Butyl-6,7-dichloro-2-cyclopentyl-indan-1-on-5-yl) oxobutyric acid inhibits angiogenesis
    Zhou T; Li Y; Zhang H; Pan L; Pang J; Yuan Q; Li G; Jie L; Wang Y; Zhang Y
    Front Cardiovasc Med; 2022; 9():969616. PubMed ID: 36211567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways.
    Wang M; Zhang C; Zheng Q; Ma Z; Qi M; Di G; Ling S; Xu H; Qi B; Yao C; Xia H; Jiang X
    Int J Biol Sci; 2022; 18(3):942-955. PubMed ID: 35173528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway.
    Boulan B; Ravanello C; Peyrel A; Bosc C; Delphin C; Appaix F; Denarier E; Kraut A; Jacquier-Sarlin M; Fournier A; Andrieux A; Gory-Fauré S; Deloulme JC
    Elife; 2021 Dec; 10():. PubMed ID: 34860155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nck adaptors at a glance.
    Bywaters BC; Rivera GM
    J Cell Sci; 2021 Sep; 134(18):. PubMed ID: 34558601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights on the role of vascular endothelial growth factor in biliary pathophysiology.
    Mariotti V; Fiorotto R; Cadamuro M; Fabris L; Strazzabosco M
    JHEP Rep; 2021 Jun; 3(3):100251. PubMed ID: 34151244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinner or Saint?: Nck Adaptor Proteins in Vascular Biology.
    Alfaidi M; Scott ML; Orr AW
    Front Cell Dev Biol; 2021; 9():688388. PubMed ID: 34124074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role.
    Wang X; Bove AM; Simone G; Ma B
    Front Cell Dev Biol; 2020; 8():599281. PubMed ID: 33304904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounds from Natural Sources as Protein Kinase Inhibitors.
    Baier A; Szyszka R
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33198400
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.